Drug Delays Rheumatoid Arthritis Progression
Links shared publicly online about this topic
How Does Rheumatoid Arthritis Develop and Progress?
patient.co.uk — “Rheumatoid arthritis causes inflammation, pain, and swelling of joints. Persistent inflammation over time can damage affected joints. The severity can vary from mild to severe. Treatments include disease-modifying drugs to suppress inflammation which can prevent or delay the progression of the disease, and medication to ease pain. The earlier treatment is started, the less joint damage is likely to occur. Surgery is needed in some cases if a joint becomes badly damaged.” View full resource at patient.co.uk
Most Recently Shared on January 2, 2010 at 8:48 pm By:
Nicholas Cappello MD Orthopedic Surgeon, Physician, Doctor, and Surgeon
Rheumatoid Arthritis | Health | Patient UK http://www.patient.co.uk/health/Rheumatoid-Arthritis.htm
Roche drug helps halt rheumatoid arthritis progress | Reuters
reuters.com — “* Actemra helps halt RA progression at 2 years -- study * Actemra plus methotrexate tops methotrexate alone * At 8mg/kg dose, 83 pct had no joint damage progression By Bill Berkrot NEW YORK, Oct” View full resource at reuters.com
Most Recently Shared on December 3, 2009 at 8:45 pm By:
Roche drug helps halt rheumatoid arthritis progress … http://bit.ly/8kQw5N
Pharmacist.com | Cheaper RA medications may be similar to biologics in slowing radiographic progression of RA
pharmacist.com — “A recent meta-analysis showed that disease-modifying antirheumatic drugs, glucocorticoids, biologics, and a combination of these agents were all effective at reducing radiographic evidence of joint destruction in patients with RA.” View full resource at pharmacist.com
Most Recently Shared on February 5, 2011 at 4:18 am By:
Dr OP Garg Rheumatologist, Physician, Doctor, and Internist
Very imp for RA patients: You must know: a new analysis concluded that DMARDs are effective at reducing joint... http://fb.me/AdewEOCk
Rheumatology Article | Arthritis, Rheumatoid
mdlinx.com — “Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors” View full resource at mdlinx.com
Most Recently Shared on September 14, 2011 at 9:57 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic dise... http://t.co/ELPQc0k4 #Rheumatology
SSRIs Offer Model For Drug Development Opportunities To Treat Rheumatoid Arthritis
medicalnewstoday.com — “A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sand” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 7:09 pm By:
MNT Arthritis News Health News
SSRIs Offer Model For Drug Development Opportunities To Treat Rheumatoid Arthritis http://mnt.to/3yd8 #arthritis
Better Outcomes Seen With Early Rheumatoid Arthritis Diagnosis - MSN Health - Arthritis
health.msn.com — “Delay of 12 weeks or more after onset of symptoms linked to more joint destruction study finds” View full resource at health.msn.com
Most Recently Shared on November 30, 2010 at 7:41 pm By:
Better Outcomes Seen With Early Rheumatoid Arthritis Diagnosis: http://on-msn.com/dF0kh4
Non-surgical Treatments for Rheumatoid Arthritis
spineuniverse.com — “Most patients with rheumatoid arthritis (RA) can be treated non-surgically. The treatment plan is designed to control the disease, alleviate pain, and maximize quality of life. Options include medications and physical therapy.” View full resource at spineuniverse.com
Most Recently Shared on July 10, 2009 at 2:03 pm By:
While there's no cure for rheumatoid arthritis (yet!), there are many non-surgical treatments. Know your options: http://tinyurl.com/mlqx66
Drug 'stops progress of arthritis' | NHS Choices | Nursing Times
nursingtimes.net — “Up to 250,000 rheumatoid arthritis sufferers could benefit from a drug that can halt the disease in its tracks, according to The Daily Telegraph.Brought to you by NHS Choices” View full resource at nursingtimes.net
Most Recently Shared on June 18, 2009 at 12:29 am By:
Behind the Headlines Drug 'stops progress of arthritis': Up to 250,000 rheumatoid arthritis .. http://tinyurl.com/lpbpny
Too Few Get Needed Rheumatoid Arthritis Drugs: Study - MSN Health - Medications
health.msn.com — “Medications that slow disease's progression aren't prescribed enough researchers say” View full resource at health.msn.com
Most Recently Shared on February 1, 2011 at 9:29 pm By:
Too Few Get Needed Rheumatoid Arthritis Drugs: Study: http://on-msn.com/geNhBU
Enbrel Patent Could Delay Generic Competition Until 2028 | Rheumatoid Arthritis Guy
rheumatoidarthritisguy.com — ““Amgen said Tuesday that a new patent had been granted that could protect its big-selling drug Enbrel from generic competition for 17 more years, a development…” View full resource at rheumatoidarthritisguy.com
Most Recently Shared on November 24, 2011 at 1:47 am By:
Enbrel Patent Could Delay Generic Competition Until 2028 http://t.co/4OmeavTa (via @GinaRClark) #rheum
UCB (BE) - Cimzia (certolizumab pegol) shows sustained clinical improvements over three years and inhibition of joint progression in patients with rheumatoid arthritis - Drugs.com MedNews
drugs.com — “In adult patients with moderate to severely active rheumatoid arthritis, Cimzia provided rapid and sustained improvements in ACR responses, DAS 28 scores, HAQ-D” View full resource at drugs.com
Most Recently Shared on June 16, 2010 at 8:45 pm By:
UCB (BE) - Cimzia (certolizumab pegol) shows sustained clinical improvements over three years and inhibition of jo... http://bit.ly/91qZTL
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Anti-TNF Agents for the Treatment of Rheumatoid Arthritis - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on August 26, 2010 at 2:56 pm By:
Miriam E. Tucker Patient Expert
RT @NIAIDNews: #Rheumatoid #arthritis patients ages 18-75 needed to participate in NIAID treatment #clinicaltrial http://go.usa.gov/cwb
Centocor Ortho Biotech Inc. Submits Application To FDA Seeking To Expand SIMPONI(R) Label In Treatment Of Rheumatoid Arthritis
medicalnewstoday.com — “Centocor Ortho Biotech Inc. announced today that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking to expand the SIMPONI&r” View full resource at medicalnewstoday.com
Most Recently Shared on September 28, 2010 at 12:05 pm By:
MNT Arthritis News Health News
Centocor Ortho Biotech Inc. Submits Application To FDA Seeking To Expand SIMPONI(R) Label In Treatment Of Rheumatoid A... http://mnt.to/3Kq5
Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia (certolizumab pegol), According to Data Being Highlighted During ACR Meeting - Drugs.com MedNews
drugs.com — “- Guide to Cimzia data (certolizumab pegol) and other UCB-sponsored research for science writers interested in American College of Rheumatology 2010 Annual Scie” View full resource at drugs.com
Most Recently Shared on November 5, 2010 at 6:12 pm By:
Drugs and Devices OW OW Health
Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia (certolizum... http://bit.ly/akHgF3 #drug
Statins linked to lower rheumatoid arthritis risk: LONDON (Reuters) - Israeli scientists have found a significant ... http://bit.ly/bSiSfu
reuters.com — “Statins linked to lower rheumatoid arthritis risk: LONDON (Reuters) - Israeli scientists have found a significant ... http://bit.ly/bSiSfu” View full resource at reuters.com
Most Recently Shared on September 8, 2010 at 8:14 pm By:
HealthIT Policy Health News and Health IT
Statins linked to lower rheumatoid arthritis risk: LONDON (Reuters) - Israeli scientists have found a significant ... http://bit.ly/bSiSfu
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Nicholas Cappello MD
American Orthopedic Surgeon, who in April of 2001 decided to explore the Middle East. Life of Traveling and meeting people of different cultures
-
Bo
Internet Entrepreneur interested in health issues, co-founder of DrEveryone.com
-
Dr OP Garg
Col.OPGarg,VSM- Consultant Rheumatologist at BLK Hospital, Delhi. Ex Rheumatologist @Army Hospital R&R. Army Officer for life. Fuses technology with medicine
Advertisement
